Oxybutynin for Neurogenic Bladder

Safety and effectiveness of oxybutynin in children (6-16 years) with neurogenic bladder

Who may qualify:

Patients 6-16 years old with neurogenic detrusor overactivity

Who does not qualify:

Patients who are pregnant, involved in other investigational studies or have certain medical conditions

Medication Under Study:
Oxybutynin Chloride

Full IRB Study Title:
A Multi-Center, Double-Blind, Placebo-Controlled, Dose-Titration Study Evaluating the Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of Oxybutynin Chloride Topical Gel for the Treatment of Detrusor Overactivity Associated with a Neurological Condition in Pediatric Subjects

IRB Study ID:

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-5012

or, Rebecca D. Considine Research Institute, 330-543-5012

Lead Principal Investigator:

Daniel McMahon, MD
Director, Pediatric Urology

Bookmark and Share

Developments Developments
Sign up for enewsletter
Get involved Get involved
Discover ways to support Akron Children's
    Contact Us



    find a location
    Find a location Type the first 3-5 letters of a specialty, service or location:
    Or, view: a map, a list of all locations, locations by city or locations near me.
    find a doctor
    Find a doctor Type the first 3-5 letters of the name, location or specialty:
    Or, view a list of all doctors by name, location and specialty.